| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |